C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug.

To learn more about LGM Pharma’s unique integrated suite of API sourcing and drug product CDMO services, visit LGM Pharma’s Booth (#1615) at CPhI North America, May 17-19, 2022, Philadelphia ...

Active Pharmaceutical Ingredients (API) Market to Amass $359.45 Billion by 2030 at CAGR 5.85% - Grand View Research, Inc. PR Newswire Tue, Apr 29, 2025, 7:05 AM 7 min read ...

Shanghai, China: Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients (API) from India, and is also planning to invest in ...

Summary India’s active pharmaceutical ingredient (API) business has been catapulted from pariah to private equity darling. The Indian pharma industry seems to be at yet another major inflection ...

Contacts. IR Contacts. United States Ran Meir (267) 468-4475 Israel Yael Ashman 972 (3) 914-8262 PR Contacts. United States Kelley Dougherty (973) 658-0237 Israel Eden Klein 972 (3) 906-2645 ...

For instance, the price of paracetamol API soared from Rs 900 per kg during the pandemic to Rs 600 shortly after, but it has now decreased to Rs 250 per kg. Similarly, the cost of meropenem API ...

Mumbai, June 13 -- NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active Pharmaceutical Ingredients (API) Unit The U.S. Food and Drug Administration (FDA) had con ...

Orchid Pharma's Alathur API facility successfully completes US FDA inspection: Our Bureau, Mumbai Thursday, February 20, 2025, 11:30 Hrs [IST] Orchid Pharma Ltd., a vertically integrated ...

pharmaand GmbH (pharma&) has received a regulatory variation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), authorizing its wholly owned subsidiary, Loba biotech GmbH, as an ...

The global plant-based Active Pharmaceutical Ingredient (API) market is projected to grow at a steady pace, reaching a valuation of $52.1 billion by 2034, according to a new report by Future ...